US Stock MarketDetailed Quotes

DXCM DexCom

Watchlist
  • 130.840
  • +0.150+0.11%
Close May 21 16:00 ET
  • 130.190
  • -0.650-0.50%
Post 19:35 ET
52.03BMarket Cap84.96P/E (TTM)

About DexCom Company

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Company Profile

SymbolDXCM
Company NameDexCom
Listing DateApr 14, 2005
Issue Price12.00
Founded1999
MarketNASDAQ
Employees9600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6340 Sequence Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-200-0200

Company Executives

  • Name
  • Position
  • Salary
  • Kevin R. Sayer, C.P.A.
  • President, Chief Executive Officer and Chairman of the Board
  • 15.71M
  • Sadie Stern
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Michael Brown
  • Executive Vice President and Chief Legal Officer
  • 4.34M
  • Teri L Lawver
  • Executive Vice President and Chief Commercial Officer
  • 6.53M
  • Jereme M. Sylvain
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 4.25M
  • Jake Leach
  • Executive Vice President and Chief Operating Officer
  • 4.94M
  • Matthew Vincent Dolan
  • Executive Vice President, Strategy, Corporate Development and Dexcom Labs
  • --
  • Professor Dr. Eric J. Topol, M.D.
  • Independent Director
  • 346.49K
  • Steven R. Altman
  • Independent Director
  • 343.40K
  • Karen M. Dahut
  • Independent Director
  • 345.90K
  • Bridgette P. Heller
  • Independent Director
  • 346.49K
  • Nicholas Augustinos
  • Independent Director
  • 362.21K
  • Rimma Driscoll
  • Independent Director
  • 404.72K
  • Richard A. Collins
  • Independent Director
  • 345.90K
  • Mark G. Foletta
  • Lead Independent Director
  • 393.51K
  • Kyle Malady
  • Independent Director
  • 343.40K
  • Dr. Barbara E. Kahn
  • Independent Director
  • 348.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg